Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers-Reference-Cited by-同舟云学术

Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers

Published:2017-09-29 Issue:10 Volume:19 Page:1988-1996
ISSN:1526-2375
Container-title:Pain Medicine
language:en
Short-container-title:

Author:

Priestley Tony¹,Chappa Arvind K¹,Mould Diane R²,Upton Richard N²,Shusterman Neil¹,Passik Steven¹,Tormo Vicente J¹,Camper Stephen¹

Affiliation:

1. Endo Pharmaceuticals Inc., Malvern, Pennsylvania

2. Projections Research, Inc., Phoenixville, Pennsylvania, USA

Funder

Endo Pharmaceuticals Inc

Publisher

Oxford University Press (OUP)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,General Medicine

Link

http://academic.oup.com/painmedicine/article-pdf/19/10/1988/25842049/pnx235.pdf

Reference34 articles.

1. Buprenorphine—an attractive opioid with underutilized potential in treatment of chronic pain;Khanna;J Pain Res,2015

2. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: Norbuprenorphine is a potent opioid agonist;Huang;J Pharmacol Exp Ther,2001

3. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice;Kogel;Eur J Pain,2005

4. The kappa opioid receptor: From addiction to depression, and back;Lalanne;Front Psychiatry,2014

5. Association of in vivo K-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology;Pietrzak;JAMA Psychiatry,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder;Addiction Science & Clinical Practice;2024-06-18

2. Buprenorphine for Pain: A Narrative Review and Practical Applications;The American Journal of Medicine;2024-05

3. Frontline Perspectives on Buprenorphine for the Management of Chronic Pain;Journal of Multidisciplinary Healthcare;2024-03

4. 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine;Journal of Addiction Medicine;2023-10-17

5. Analgesic Effect of Buprenorphine for Chronic Noncancer Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Anesthesia & Analgesia;2023-06-16